Whalerock Point Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-682
Closed -$239K 201
2025
Q4
$239K Hold
682
0.05% 178
2025
Q3
$220K Hold
682
0.04% 172
2025
Q2
$265K Hold
682
0.06% 165
2025
Q1
$297K Sell
682
-195
-22% -$78.3K 0.07% 149
2024
Q4
$324K Hold
877
0.08% 142
2024
Q3
$456K Hold
877
0.11% 114
2024
Q2
$475K Hold
877
0.13% 93
2024
Q1
$455K Hold
877
0.12% 107
2023
Q4
$414K Hold
877
0.13% 105
2023
Q3
$382K Hold
877
0.13% 102
2023
Q2
$390K Buy
877
+32
+4% +$14.8K 0.13% 102
2023
Q1
$389K Hold
845
0.14% 97
2022
Q4
$433K Hold
845
0.18% 87
2022
Q3
$384K Hold
845
0.17% 92
2022
Q2
$408K Hold
845
0.17% 86
2022
Q1
$415K Hold
845
0.15% 98
2021
Q4
$392K Hold
845
0.13% 105
2021
Q3
$315K Hold
845
0.12% 106
2021
Q2
$323K Hold
845
0.12% 109
2021
Q1
$303K Hold
845
0.13% 104
2020
Q4
$271K Buy
845
+618
+272% +$190K 0.13% 105
2020
Q3
$227K Sell
227
-618
-73% -$166K 0.13% 105
2020
Q2
$222K Buy
+845
New +$225K 0.13% 109
2020
Q1
Sell
-852
Closed -$257K 124
2019
Q4
$257K Buy
852
+7
+0.8% +$1.93K 0.14% 125
2019
Q3
$203K Hold
845
0.11% 140
2019
Q2
$238K Hold
845
0.14% 129
2019
Q1
$242K Buy
+845
New +$244K 0.16% 115

Other funds holding ELV

Whalerock Point Partners's ELV Position: Q1 2026 in Review

Whalerock Point Partners sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 682 shares — an estimated $239K sold.

Whalerock Point Partners first reported a position in ELV in Q1 2019 and held it in 27 quarters. The position peaked at $475K in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Whalerock Point Partners reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Whalerock Point Partners sold 682 Elevance Health shares in Q1 2026, an estimated $239K.
  • Whalerock Point Partners first reported a position in Elevance Health in Q1 2019 and held it in 27 quarters.
  • Whalerock Point Partners's Elevance Health position peaked at $475K in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Whalerock Point Partners's 13F filing for Q1 2026, filed 15 May 2026.